Source link : https://newshealth.biz/health-news/full-year-data-back-tyk2-blocker-in-psoriatic-arthritis/
(MedPage Today) — CHICAGO — Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in the near future, with results after 1 year reported here from one of its key phase III trials. Further… Source link : https://www.medpagetoday.com/meetingcoverage/acr/118248 Author : Publish date : 2025-10-31 13:00:00 Copyright for syndicated content […]
The post Full-Year Data Back TYK2 Blocker in Psoriatic Arthritis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-31 13:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8